{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:13:35Z","timestamp":1753877615395,"version":"3.41.2"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["5K23DA054363"],"award-info":[{"award-number":["5K23DA054363"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Addiction Research and Education Unit at Boston Medical Center","award":["NIDA 5R25DA013582"],"award-info":[{"award-number":["NIDA 5R25DA013582"]}]},{"name":"Boston University Chobanian and Avedisian School of Medicine"},{"DOI":"10.13039\/100007161","name":"Boston University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007161","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boston Medical Center Department of Medicine Career Investment Award"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Serious injection-related infections (SIRIs) have high morbidity and mortality, in part from incomplete antibiotic treatment, ongoing substance use and reinfection. Understanding how hospitalizations for SIRIs affect patient perspectives on substance use, harm reduction, and medications for opioid use disorder (MOUD) in the era of hospital-based addiction services will inform efforts to improve care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted qualitative interviews at Boston Medical Center with individuals hospitalized with SIRIs between 2020 and 2024. To ensure diverse experiences, we recruited qualifying participants based on record of SIRI International Classification of Diseases, 10th Revision, codes, presence on the outpatient parenteral antibiotic program list, during hospitalizations, and from a drop-in harm reduction program. Interviews were transcribed, coded inductively, and analyzed for key themes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Participants with SIRIs (n = 30) had the following characteristics: Most had endocarditis (n = 10) or osteomyelitis (n = 9) and had completed the recommended antibiotics (n = 24); the mean age was 39; most were male (n = 19), White (n = 21), and housed (n = 18). Three key themes emerged after SIRI hospitalization: (1) reduced substance use and adoption of harm reduction practices were common; (2) perspectives on MOUD varied, but negative experiences and medication stigma persisted; and (3) SIRI hospitalizations were viewed as an opportunity for reflection on substance use and health.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>SIRI hospitalizations and the postdischarge period are opportunities to engage patients in addiction and infectious disease care. Participants expressed ambivalence about MOUD despite access to robust hospital-based addiction medicine services. Longitudinal support that explicitly includes harm reduction and MOUD, both linkage and retention, is needed to improve care for people with SIRIs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf201","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T21:18:48Z","timestamp":1743455928000},"source":"Crossref","is-referenced-by-count":0,"title":["\u201cEvery Time I Go in There, It Gives Me Time to Reflect\u201d: A Qualitative Study of Patient Perspectives on Substance Use, Medications for Opioid Use Disorder, and Harm Reduction Following Hospitalization for Serious Injection-Related Infection"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7802-9540","authenticated-orcid":false,"given":"Thisara","family":"Jayasinghe","sequence":"first","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center , Boston, Massachusetts ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7214-8037","authenticated-orcid":false,"given":"Mari-Lynn","family":"Drainoni","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Health, Law and Policy, Boston University School of Public Health , Boston, Massachusetts ,","place":["USA"]},{"name":"Evans Center for Implementation and Improvement Sciences, Boston University , Boston, Massachusetts ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8158-4882","authenticated-orcid":false,"given":"Alexander","family":"Walley","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center , Boston, Massachusetts ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0664-3248","authenticated-orcid":false,"given":"Christine","family":"Grella","sequence":"additional","affiliation":[{"name":"Semel Institute of Neuroscience and Human Behavior, David Geffen School of Medicine, University of California-Los Angeles, California, USA, and the Lighthouse Institute, Chestnut Health Systems , Chicago, Illinois ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Majeski","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center , Boston, Massachusetts ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Rolles","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center , Boston, Massachusetts ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ally","family":"Cogan","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center , Boston, Massachusetts ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7940-9097","authenticated-orcid":false,"given":"Guhan","family":"Venkatesan","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center , Boston, Massachusetts ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2466-5192","authenticated-orcid":false,"given":"Michael D","family":"Stein","sequence":"additional","affiliation":[{"name":"Department of Health, Law and Policy, Boston University School of Public Health , Boston, Massachusetts ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7344-1200","authenticated-orcid":false,"given":"Marc","family":"Larochelle","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center , Boston, Massachusetts ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0897-3400","authenticated-orcid":false,"given":"Jeffrey H","family":"Samet","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Community Health Sciences, Boston University School of Public Health , Boston, Massachusetts ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5029-9384","authenticated-orcid":false,"given":"Simeon D","family":"Kimmel","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center , Boston, Massachusetts ,","place":["USA"]},{"name":"Section of Infectious Diseases, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center , Boston, Massachusetts ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"2025052306580761000_ofaf201-B1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N Engl J Med"},{"key":"2025052306580761000_ofaf201-B2","doi-asserted-by":"crossref","first-page":"E650","DOI":"10.1093\/cid\/ciaa365","article-title":"Evaluation of partial oral antibiotic treatment for persons who inject drugs and are hospitalized with invasive infections","volume":"71","author":"Marks","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025052306580761000_ofaf201-B3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.2020.2559","article-title":"Integrating responses to the opioid use disorder and infectious disease epidemics: a report from the National Academies of Sciences, Engineering, and Medicine","volume":"324","author":"Springer","year":"2020","journal-title":"JAMA"},{"key":"2025052306580761000_ofaf201-B4","doi-asserted-by":"crossref","first-page":"e2016228","DOI":"10.1001\/jamanetworkopen.2020.16228","article-title":"Association of treatment with medications for opioid use disorder with mortality after hospitalization for injection drug use-associated infective endocarditis","volume":"3","author":"Kimmel","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025052306580761000_ofaf201-B5","doi-asserted-by":"crossref","first-page":"108207","DOI":"10.1016\/j.drugalcdep.2020.108207","article-title":"Impact of medications for opioid use disorder among persons hospitalized for drug use-associated skin and soft tissue infections","volume":"215","author":"Barocas","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"2025052306580761000_ofaf201-B6","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/cid\/ciy924","article-title":"Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder","volume":"68","author":"Marks","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2025052306580761000_ofaf201-B7","doi-asserted-by":"crossref","first-page":"e2421740","DOI":"10.1001\/jamanetworkopen.2024.21740","article-title":"Medication for opioid use disorder after serious injection-related infections in Massachusetts","volume":"7","author":"Kimmel","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2025052306580761000_ofaf201-B8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.mcna.2018.03.001","article-title":"Inpatient addiction consult service: expertise for hospitalized patients with complex addiction problems","volume":"102","author":"Weinstein","year":"2018","journal-title":"Med Clin North Am"},{"key":"2025052306580761000_ofaf201-B9","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1080\/07853890.2021.1993326","article-title":"Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI team","volume":"53","author":"Serota","year":"2021","journal-title":"Ann Med"},{"key":"2025052306580761000_ofaf201-B10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12879-022-07122-x","article-title":"Antibiotic therapy completion for injection drug use-associated infective endocarditis at a center with routine addiction medicine consultation: a retrospective cohort study","volume":"22","author":"Dhanani","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2025052306580761000_ofaf201-B11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsat.2019.04.008","article-title":"Experiences of care among individuals with opioid use disorder-associated endocarditis and their healthcare providers: results from a qualitative study","volume":"102","author":"Bearnot","year":"2019","journal-title":"J Subst Abuse Treat"},{"key":"2025052306580761000_ofaf201-B12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11606-010-1311-3","article-title":"A transitional opioid program to engage hospitalized drug users","volume":"25","author":"Shanahan","year":"2010","journal-title":"J Gen Intern Med"},{"key":"2025052306580761000_ofaf201-B13","doi-asserted-by":"crossref","first-page":"108081","DOI":"10.1016\/j.drugalcdep.2020.108081","article-title":"Inpatient addiction consultation and post-discharge 30-day acute care utilization","volume":"213","author":"Weinstein","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"2025052306580761000_ofaf201-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2017.05.007","article-title":"Addiction consultation services\u2014linking hospitalized patients to outpatient addiction treatment","volume":"79","author":"Trowbridge","year":"2017","journal-title":"J Subst Abuse Treat"},{"key":"2025052306580761000_ofaf201-B15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/CXA.0000000000000080","article-title":"Harm reduction for injection drug users with infective endocarditis: a systematic review","volume":"11","author":"Bahji","year":"2020","journal-title":"CanJ Addict"},{"key":"2025052306580761000_ofaf201-B16","doi-asserted-by":"crossref","first-page":"109608","DOI":"10.1016\/j.drugalcdep.2022.109608","article-title":"Harm reduction in the hospital: an overdose prevention site (OPS) at a Canadian hospital","volume":"239","author":"Nolan","year":"2022;","journal-title":"Drug Alcohol Depend"},{"key":"2025052306580761000_ofaf201-B17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/add.13214","article-title":"Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals","volume":"111","author":"McNeil","year":"2016","journal-title":"Addiction"},{"key":"2025052306580761000_ofaf201-B18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12954-022-00622-8","article-title":"Integration of a community-based harm reduction program into a safety net hospital: a qualitative study","volume":"19","author":"Khan","year":"2022","journal-title":"Harm Reduct J"},{"key":"2025052306580761000_ofaf201-B19","doi-asserted-by":"crossref","first-page":"108924","DOI":"10.1016\/j.jsat.2022.108924","article-title":"Identifying factors that contribute to burnout and resilience among hospital-based addiction medicine providers: a qualitative study","volume":"144","author":"Bredenberg","year":"2023","journal-title":"J Subst Abuse Treat"},{"key":"2025052306580761000_ofaf201-B20","first-page":"11782218221103859","article-title":"You\u2019re not supposed to be on it forever\u201d: medications to treat opioid use disorder (MOUD) related stigma among drug treatment providers and people who use opioids","volume":"16","author":"Dickson-Gomez","year":"2022","journal-title":"Subst Abuse"},{"key":"2025052306580761000_ofaf201-B21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.socscimed.2008.06.004","article-title":"Are drug treatment services only for \u2018thieving junkie scumbags\u2019? Drug users and the management of stigmatised identities","volume":"67","author":"Radcliffe","year":"2008","journal-title":"Soc Sci Med"},{"key":"2025052306580761000_ofaf201-B22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cid\/ciz869","article-title":"Long-term outcomes are poor in intravenous drug users following infective endocarditis, even after surgery","volume":"71","author":"Straw","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025052306580761000_ofaf201-B23","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz089","article-title":"High morbidity and mortality among patients with sentinel admission for injection drug use-related infective endocarditis","author":"Leahey","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025052306580761000_ofaf201-B24","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S2468-2667(23)00023-3","article-title":"Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy","volume":"8","author":"Krawczyk","year":"2023","journal-title":"Lancet Public Health"},{"key":"2025052306580761000_ofaf201-B25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11606-016-3919-4","article-title":"It's been an experience, a life learning experience\u201d: a qualitative study of hospitalized patients with substance use disorders","volume":"32","author":"Velez","year":"2017","journal-title":"J Gen Intern Med"},{"key":"2025052306580761000_ofaf201-B26","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.addbeh.2006.01.003","article-title":"Does this patient really want treatment? Factors associated with baseline and evolving readiness for change among hospitalized substance using adults interested in treatment","volume":"31","author":"Pollini","year":"2006","journal-title":"Addict Behav"},{"key":"2025052306580761000_ofaf201-B27","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1080\/08897077.2021.2007520","article-title":"Characteristics associated with motivation to stop substance use and improve skin and needle hygiene among hospitalized patients who inject drugs","volume":"43","author":"Kimmel","year":"2022","journal-title":"Subst Abus"},{"key":"2025052306580761000_ofaf201-B28","doi-asserted-by":"crossref","first-page":"108708","DOI":"10.1016\/j.jsat.2021.108708","article-title":"Experiences of stigma in hospitals with addiction consultation services: a qualitative analysis of patients\u2019 and hospital-based providers\u2019 perspectives","volume":"138","author":"Hoover","year":"2022","journal-title":"J Subst Abuse Treat"},{"key":"2025052306580761000_ofaf201-B29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.socscimed.2014.01.010","article-title":"Hospitals as a \u2018risk environment\u2019: an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs","volume":"105","author":"McNeil","year":"2014","journal-title":"Soc Sci Med"},{"key":"2025052306580761000_ofaf201-B30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","article-title":"Strategies used by people who inject drugs to avoid stigma in healthcare settings","volume":"198","author":"Biancarelli","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"2025052306580761000_ofaf201-B31","first-page":"20499361231165108","article-title":"I feel like they\u2019re actually listening to me\u201d: a pilot study of a hospital discharge decision-making conversation guide for patients with injection drug use-associated infections","volume":"10","author":"Thakarar","year":"2023","journal-title":"Ther Adv Infect Dis"},{"key":"2025052306580761000_ofaf201-B32","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1093\/cid\/ciad664","article-title":"Frame shift: focusing on harm reduction and shared decision making for people who use drugs hospitalized with infections","volume":"78","author":"Thakarar","year":"2024","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf201\/62847957\/ofaf201.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/5\/ofaf201\/62847957\/ofaf201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/5\/ofaf201\/62847957\/ofaf201.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:58:18Z","timestamp":1747997898000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf201\/8104717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf201","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,4,3]]},"article-number":"ofaf201"}}